BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15811864)

  • 1. Letter regarding article by Hlatky et al, "medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease".
    Osman F; Qaisar S; Pitt M
    Circulation; 2005 Apr; 111(13):e176-7; author reply e176-7. PubMed ID: 15811864
    [No Abstract]   [Full Text] [Related]  

  • 2. Landmarks: examining the foundation for GP IIb/IIIa inhibitors in PCI.
    J Invasive Cardiol; 2002 Dec; 14(12):776-9. PubMed ID: 12537005
    [No Abstract]   [Full Text] [Related]  

  • 3. Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease.
    Hlatky MA; Boothroyd DB; Melsop KA; Brooks MM; Mark DB; Pitt B; Reeder GS; Rogers WJ; Ryan TJ; Whitlow PL; Wiens RD
    Circulation; 2004 Oct; 110(14):1960-6. PubMed ID: 15451795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Percutaneous coronary intervention in diabetic patients].
    Lablanche JM; Rosey G; Zoubidi M; Sudre A
    Bull Acad Natl Med; 2005 Feb; 189(2):249-56. PubMed ID: 16114856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolving role of glycoprotein (GP) IIb/IIIa receptor blockade during percutaneous coronary intervention of saphenous vein bypass grafts.
    D'Agate DJ; Patel S; Coppola JT; Ambrose JA
    J Invasive Cardiol; 2004 Sep; 16(9):500-3. PubMed ID: 15353833
    [No Abstract]   [Full Text] [Related]  

  • 6. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
    Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary treatment of coronary bifurcations with drug-eluting stent: part II.
    Colombo A
    J Interv Cardiol; 2006 Feb; 19(1):51-3. PubMed ID: 16483340
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet glycoprotein IIb/IIIa receptor inhibitors: is their future as bright as their past?
    Leesar MA
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):907-8. PubMed ID: 18498141
    [No Abstract]   [Full Text] [Related]  

  • 9. Has anything changed in multivessel coronary artery revascularization in diabetes since BARI?
    Kapur A; Bartolini D; Beatt KJ
    Ital Heart J; 2004 May; 5(5):358-63. PubMed ID: 15185899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials.
    Mercado N; Wijns W; Serruys PW; Sigwart U; Flather MD; Stables RH; O'Neill WW; Rodriguez A; Lemos PA; Hueb WA; Gersh BJ; Booth J; Boersma E
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):512-9. PubMed ID: 16077421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivessel coronary artery disease: how do we treat it?
    Sharma S
    Timely Top Med Cardiovasc Dis; 2007 Jul; 11():E15. PubMed ID: 18297143
    [No Abstract]   [Full Text] [Related]  

  • 12. Multivessel disease: percutaneous coronary intervention for classic coronary artery bypass grafting indications.
    Brar SS; Syros G; Dangas G
    Angiology; 2008; 59(2 Suppl):83S-8S. PubMed ID: 18544582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular disease in diabetes.
    Sigal R; Malcolm J; Meggison H
    Clin Evid; 2002 Jun; (7):498-520. PubMed ID: 12230676
    [No Abstract]   [Full Text] [Related]  

  • 14. [Percutaneous coronary intervention].
    Csapó K
    Orv Hetil; 2005 Mar; 146(13):587-93. PubMed ID: 15856622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolving role of glycoprotein IIb/IIIa inhibitor therapy in contemporary care of acute coronary syndrome patients.
    Tricoci P; Peterson ED
    J Interv Cardiol; 2006 Oct; 19(5):449-55. PubMed ID: 17020570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of four randomized controlled trials on long-term outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with stenting for multivessel coronary artery disease.
    Takagi H; Kawai N; Umemoto T
    Am J Cardiol; 2008 May; 101(9):1259-62. PubMed ID: 18435954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: one-year results from the Stent or Surgery (SoS) trial.
    Zhang Z; Mahoney EM; Spertus JA; Booth J; Nugara F; Kolm P; Stables RH; Weintraub WS
    Am Heart J; 2006 Dec; 152(6):1153-60. PubMed ID: 17161069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes after multilesion percutaneous coronary intervention: comparison between exclusive and selective use of drug-eluting stents.
    Bertrand OF; Faurie B; Larose E; Nguyen CM; Gleeton O; Déry JP; Noël B; Proulx G; Roy L; Costerousse O; De Larochellière R; Rodés-Cabau J
    J Invasive Cardiol; 2008 Mar; 20(3):99-104. PubMed ID: 18316823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007.
    Daemen J; Simoons ML; Wijns W; Bagust A; Bos G; Bowen JM; Braunwald E; Camenzind E; Chevaliers B; DiMario C; Fajadeto J; Gitt A; Guagliumi G; Hillege HL; James S; Jüni P; Kastrati A; Kloth S; Kristensen SD; Krucoff M; Legrand V; Pfisterer M; Rothman M; Serruys PW; Silber S; Steg PG; Tariah I; Wallentin L; Windecker SW; Aimonetti A; Allocco D; Berenger M; Boam A; Calle JP; Campo G; Carlier S; de Schepper J; Di Bisceglie G; Dobbels H; Farb A; Ghislain JC; Hellbardt S; ten Hoedt R; Isaia C; de Jong P; Lekehal M; LeNarz L; Mhullain FN; Nagai H; Patteet A; Paunovic D; Potgieter A; Purdy I; Raveau-Landon C; Ternstrom S; Van Wuytswinkel J; Waliszewski M;
    EuroIntervention; 2009 Jan; 4(4):427-36. PubMed ID: 19284063
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials.
    Daemen J; Boersma E; Flather M; Booth J; Stables R; Rodriguez A; Rodriguez-Granillo G; Hueb WA; Lemos PA; Serruys PW
    Circulation; 2008 Sep; 118(11):1146-54. PubMed ID: 18725490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.